Tacrolimus is an immunosuppressive agent used for prophylaxis of organ rejection post-transplant. Tacrolimus use is in combination with one or, most commonly, twoÂ other immunosuppressive medications. It has an application as an agent for the prevention or treatment of certain autoimmune diseases.

In solid organ transplantation, it serves as the treatment of organ rejection in kidney, liver, and heart allogeneic transplants. There is also an off-label indication for the prevention of rejection in lung transplant patients.

Other off-label indications include:

- Crohn disease

- Graft-versus-host disease (GVHD)

- Myasthenia gravis

- Rheumatoid arthritis

Tacrolimus indications also include topical use in moderate to severe atopic dermatitis, as well as other off-label dermatologic disease states.